EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

VITAMIN D RECEPTOR (VDR) AND VITAMIN D LEVELS IN LEUKEMIA AND LYMPHOMA PATIENTS

Anggraini Iriani, Andhika Rachman, Marsya Kaila Fatina, Fiona Valerie Muskananfola, Media Fitri Isma Nugraha, Rizka Kurnia Gemilang, Andi Trisnandi

INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · 13.03.2026 · 32 (2) · 228-234

DOI: 10.24293/ijcpml.v32i2.2487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, online erschienen am 13.03.2026. Verfasst von Anggraini Iriani und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In leukemia and lymphoma, vitamin D exerts anti-tumor effects mediated by its binding to the vitamin D receptor (VDR). Vitamin D is related to cancer prognosis and response to therapy. However, the prevalence of vitamin D deficiency remains significantly high among the Indonesian population. This study aims to determine the profile of vitamin D and vitamin D receptor (VDR) levels in leukemia and lymphoma patients. This study design was a cross-sectional with a comparative analysis of vitamin D and its receptors, conducted on adult leukemia-lymphoma patients and control samples. Vitamin D examination was completed on 180 samples of 123 leukemia and lymphoma patients, and 57 controls. Vitamin D receptor (VDR) examination was conducted on 45 leukemia and lymphoma patients and 57 controls. The prevalence of vitamin D deficiency in the leukemia and lymphoma group was 85.4%. Subgroup analysis revealed that the prevalence of vitamin D deficiency was significantly higher in leukemia and lymphoma patients aged ≤40 years compared to their respective control group (p =0.039). There was no significant vitamin D receptor level between leukemia and lymphoma and the control group based on all age groups, male, and vitamin D status. Vitamin D receptor level was 0.53 (0.19) ng/mL in leukemia and lymphoma females, lower than the control group 0.73 (0.73) ng/mL, significantly. This study concluded that leukemia and lymphoma patients predominantly have vitamin D deficiency. Vitamin D receptor level is lower in females with leukemia and lymphoma than in the normal population. Vitamin D receptor can be considered as an adjunct marker in assessing vitamin D status in leukemia lymphoma cases.

Zitieren

APA

Iriani, A., Rachman, A., Fatina, M. K., Muskananfola, F. V., Nugraha, M. F. I., Gemilang, R. K., & Trisnandi, A. (2026). VITAMIN D RECEPTOR (VDR) AND VITAMIN D LEVELS IN LEUKEMIA AND LYMPHOMA PATIENTS. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 32(2), 228-234. https://doi.org/10.24293/ijcpml.v32i2.2487

Vancouver

Iriani A, Rachman A, Fatina MK, Muskananfola FV, Nugraha MFI, Gemilang RK, et al. VITAMIN D RECEPTOR (VDR) AND VITAMIN D LEVELS IN LEUKEMIA AND LYMPHOMA PATIENTS. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 2026;32(2):228-234. doi:10.24293/ijcpml.v32i2.2487

BibTeX
@article{Iriani2026,
  author = {Iriani, Anggraini and Rachman, Andhika and Fatina, Marsya Kaila and Muskananfola, Fiona Valerie and Nugraha, Media Fitri Isma and Gemilang, Rizka Kurnia and Trisnandi, Andi},
  title = {VITAMIN D RECEPTOR (VDR) AND VITAMIN D LEVELS IN LEUKEMIA AND LYMPHOMA PATIENTS},
  journal = {INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {228--234},
  doi = {10.24293/ijcpml.v32i2.2487}
}
Kostenlos starten →